2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結損益計算書及び要約四半期連結包括利益計算書
(要約四半期連結損益計算書)
| | |
| | (単位:百万円) |
| 前第3四半期連結累計期間 (自 2019年4月1日 至 2019年12月31日) | 当第3四半期連結累計期間 (自 2020年4月1日 至 2020年12月31日) |
売上収益 | 254,753 | 224,419 |
売上原価 | △40,711 | △35,947 |
売上総利益 | 214,042 | 188,471 |
販売費及び一般管理費 | △70,661 | △66,232 |
研究開発費 | △34,852 | △39,234 |
製品に係る無形資産償却費 | △2,437 | △2,406 |
その他の収益 | 2,961 | 23,315 |
その他の費用 | △2,357 | △1,712 |
営業利益 | 106,694 | 102,201 |
金融収益 | 18,478 | 15,884 |
金融費用 | △1,531 | △1,256 |
税引前四半期利益 | 123,641 | 116,830 |
法人所得税費用 | △29,332 | △30,756 |
四半期利益 | 94,308 | 86,073 |
| | |
四半期利益の帰属 | | |
親会社の所有者 | 94,260 | 86,073 |
非支配持分 | 48 | △0 |
四半期利益 | 94,308 | 86,073 |
| | |
1株当たり四半期利益 | | |
基本的1株当たり四半期利益(円) | 303.79 | 279.90 |
希薄化後1株当たり四半期利益(円) | 303.41 | 279.80 |
E0092345070塩野義製薬株式会社Shionogi & Co., Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2020-04-012020-12-31Q32021-03-312019-04-012019-12-312020-03-311falsefalsefalse450702021-02-01450702019-03-31450702020-03-31450702019-04-012019-12-31450702019-12-31450702020-04-012020-12-31450702020-12-31450702020-12-31jpigp_cor:NonControllingInterestsIFRSMember450702020-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-12-31jpigp_cor:RetainedEarningsIFRSMember450702020-12-31jpigp_cor:TreasurySharesIFRSMember450702020-12-31jpigp_cor:CapitalSurplusIFRSMember450702020-12-31jpigp_cor:ShareCapitalIFRSMember450702020-04-012020-12-31jpigp_cor:NonControllingInterestsIFRSMember450702020-04-012020-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-04-012020-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-04-012020-12-31jpigp_cor:RetainedEarningsIFRSMember450702020-04-012020-12-31jpigp_cor:TreasurySharesIFRSMember450702020-04-012020-12-31jpigp_cor:CapitalSurplusIFRSMember450702020-04-012020-12-31jpigp_cor:ShareCapitalIFRSMember450702020-03-31jpigp_cor:NonControllingInterestsIFRSMember450702020-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702020-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702020-03-31jpigp_cor:RetainedEarningsIFRSMember450702020-03-31jpigp_cor:TreasurySharesIFRSMember450702020-03-31jpigp_cor:CapitalSurplusIFRSMember450702020-03-31jpigp_cor:ShareCapitalIFRSMember450702019-12-31jpigp_cor:NonControllingInterestsIFRSMember450702019-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702019-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702019-12-31jpigp_cor:RetainedEarningsIFRSMember450702019-12-31jpigp_cor:TreasurySharesIFRSMember450702019-12-31jpigp_cor:CapitalSurplusIFRSMember450702019-12-31jpigp_cor:ShareCapitalIFRSMember450702019-04-012019-12-31jpigp_cor:NonControllingInterestsIFRSMember450702019-04-012019-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702019-04-012019-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702019-04-012019-12-31jpigp_cor:RetainedEarningsIFRSMember450702019-04-012019-12-31jpigp_cor:TreasurySharesIFRSMember450702019-04-012019-12-31jpigp_cor:CapitalSurplusIFRSMember450702019-04-012019-12-31jpigp_cor:ShareCapitalIFRSMember450702019-03-31jpigp_cor:NonControllingInterestsIFRSMember450702019-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450702019-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450702019-03-31jpigp_cor:RetainedEarningsIFRSMember450702019-03-31jpigp_cor:TreasurySharesIFRSMember450702019-03-31jpigp_cor:CapitalSurplusIFRSMember450702019-03-31jpigp_cor:ShareCapitalIFRSMemberiso4217:JPYxbrli:sharesxbrli:pureiso4217:JPY